test44
https://www.cytel.com/blog/a-bayesian-optimal-design-advancing-the-precision-medicine-approach
September 15, 2021
There is recognized heterogeneity within any given tumor‐type from patient to patient (inter‐patient heterogeneity),..
Read article
test44
https://www.cytel.com/blog/use-of-rolling-enrollment-designs-to-accelerate-clinical-trials
July 2, 2021
Popular statistical designs, such as CRM (O’Quigley et al., 1990), mTPI-2 (Guo et al., 2017), and i3+3 (Liu et al.,..
Read article
test44
https://www.cytel.com/blog/myths-surrounding-the-use-of-synthetic-control-arms-in-clinical-trials-part-3
June 24, 2021
Synthetic control arms (SCAs) leverage real world data from various sources or evaluations of historical clinical data..
Read article
test44
https://www.cytel.com/blog/2019-blog-roundup
December 18, 2019
With only two weeks left for this fabulous year to end, we would like to thank all our blog subscribers and new readers..
Read article
test44
https://www.cytel.com/blog/eugm_2019_kannannatarajan
November 5, 2019
Cytel is delighted to have Kannan Natarajan speaking at the “Complex Innovative Trial Design Symposium and East User..
Read article
